Texas 2025 89th Regular

Texas House Bill HB1837 Introduced / Bill

Filed 01/14/2025

Download
.pdf .doc .html
                    89R718 LHC-F
 By: Guillen H.B. No. 1837




 A BILL TO BE ENTITLED
 AN ACT
 relating to the enforcement and prevention of offenses involving
 the manufacture or delivery of controlled substances listed in
 Penalty Group 1-B, law enforcement officer safety in handling those
 substances, and the manufacture and proper use of opioid
 antagonists.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subchapter A, Chapter 411, Government Code, is
 amended by adding Section 411.02098 to read as follows:
 Sec. 411.02098.  FENTANYL OFFENSES ENFORCEMENT TRAINING
 PROGRAM. (a) The department, in coordination with local law
 enforcement agencies, shall establish and administer a fentanyl
 offenses enforcement training program for peace officers employed
 by local law enforcement agencies that will prepare the officers
 to:
 (1)  collaborate and cooperate with and assist any law
 enforcement agency in the interdiction, investigation, and
 prosecution of offenses under Section 481.1123, Health and Safety
 Code; and
 (2)  collaborate and cooperate with and assist district
 attorneys, county attorneys, the border prosecution unit, and other
 prosecutors in the investigation and prosecution of allegations of
 offenses under Section 481.1123, Health and Safety Code.
 (b)  The training program under Subsection (a) must include:
 (1)  information on:
 (A)  criminal activity related to a controlled
 substance listed in Penalty Group 1-B under Section 481.1022,
 Health and Safety Code, occurring along the Texas-Mexico border,
 including manufacture and delivery of those controlled substances
 carried out by cartels, transnational gangs, and other groups
 engaged in organized criminal activity; and
 (B)  methods for identifying intrastate criminal
 activity associated with the manufacture or delivery of a
 controlled substance listed in Penalty Group 1-B under Section
 481.1022, Health and Safety Code, and other organized criminal
 activity related to those controlled substances; and
 (2)  best practices for:
 (A)  the investigation and prosecution of the
 criminal activity described by Subdivision (1);
 (B)  the safest method, as determined by the
 Health and Human Services Commission, for handling a controlled
 substance listed in Penalty Group 1-B under Section 481.1022,
 Health and Safety Code; and
 (C)  the proper use of an opioid antagonist, as
 that term is defined by Section 483.101, Health and Safety Code.
 SECTION 2.  Subchapter H, Chapter 1701, Occupations Code, is
 amended by adding Section 1701.360 to read as follows:
 Sec. 1701.360.  FENTANYL OFFENSES ENFORCEMENT TRAINING
 PROGRAM. The commission may:
 (1)  recognize, or with the consent of the Department
 of Public Safety administer or assist in administering, the
 fentanyl offenses enforcement training program established under
 Section 411.02098, Government Code, as a continuing education
 program for officers; and
 (2)  credit an officer who successfully completes the
 program described by Subdivision (1) with the appropriate number of
 continuing education hours.
 SECTION 3.  (a)  In this section, "opioid antagonist" has
 the meaning assigned by Section 483.101, Health and Safety Code.
 (b)  The lethal opioid poisoning prevention task force is
 established under this section to:
 (1)  compile data on criminal activity in the
 Texas-Mexico border region related to the manufacture or delivery
 of a controlled substance listed in Penalty Group 1-B under Section
 481.1022, Health and Safety Code;
 (2)  develop best practices for:
 (A)  the investigation, interdiction, and
 prosecution of criminal activity that constitutes an offense under
 Section 481.1123, Health and Safety Code;
 (B)  the safe handling of a controlled substance
 listed in Penalty Group 1-B under Section 481.1022, Health and
 Safety Code; and
 (C)  the proper use of an opioid antagonist; and
 (3)  study methods to incentivize manufacturers of
 opioid antagonists to increase production, particularly for opioid
 antagonists to be used by law enforcement agencies of this state.
 (c)  The governor shall appoint to the task force:
 (1)  two members representing the Department of Public
 Safety;
 (2)  two members representing the Health and Human
 Services Commission; and
 (3)  two members representing the Texas Commission on
 Law Enforcement.
 (d)  Not later than six months after the date the governor
 appoints members to the task force, the task force shall submit to
 the governor and the director of the Department of Public Safety a
 report containing the data and best practices described by
 Subsections (b)(1) and (2) of this section.
 (e)  Not later than December 1, 2026, the task force shall
 submit a report to the legislature containing its findings
 regarding the methods described by Subsection (b)(3) of this
 section, including proposed legislation to increase the
 manufacturing production of opioid antagonists.
 (f)  The task force established under this section is
 abolished and this section expires January 1, 2027.
 SECTION 4.  As soon as practicable after the effective date
 of this Act, the governor shall appoint the members of the task
 force established by Section 3 of this Act.
 SECTION 5.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2025.